BCV
PACB icon

Banque Cantonale Vaudoise’s Pacific Biosciences PACB Stock Holding History

Banque Cantonale Vaudoise’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-39,046
Closed -$452K – 1216
2023
Q1 		$452K Buy
39,046
+2,756
+8% +$27.4K 0.02% 477
2022
Q4 		$297K Buy
+36,290
New +$313K 0.02% 597
2021
Q2 		– Sell
-11,890
Closed -$396K – 1271
2021
Q1 		$396K Buy
+11,890
New +$416K 0.02% 600
2020
Q4 		– Sell
-5,458
Closed -$54K – 1104
2020
Q3 		$54K Buy
+5,458
New +$31.4K ﹤0.01% 900

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Banque Cantonale Vaudoise's PACB Position: Q2 2023 in Review

Banque Cantonale Vaudoise sold out of Pacific Biosciences (PACB) in Q2 2023, closing a stake of 39,046 shares — an estimated $452K sold.

Banque Cantonale Vaudoise first reported a position in PACB in Q3 2020 and held it in 4 quarters. The position peaked at $452K in Q1 2023. 272 funds tracked by Wall St. Rank hold PACB as of Q2 2023.

  • Banque Cantonale Vaudoise reported no remaining Pacific Biosciences position as of Q2 2023 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 39,046 Pacific Biosciences shares in Q2 2023, an estimated $452K.
  • Banque Cantonale Vaudoise first reported a position in Pacific Biosciences in Q3 2020 and held it in 4 quarters.
  • Banque Cantonale Vaudoise's Pacific Biosciences position peaked at $452K in Q1 2023.
  • 272 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2023, filed 9 Aug 2023.